Morgan Stanley Signals Recovery in Investment Banking as M&A and IPO Activity Rebounds
Morgan Stanley emerges as a key beneficiary of revitalized investment banking activity, with CEO Ted Pick forecasting the strongest M&A pipeline in a decade. The firm's $299 billion in completed deals this year—though down 14% year-over-year—masks building momentum across healthcare and technology sectors.
Regulatory uncertainty had chilled dealmaking, but pent-up demand now positions Morgan Stanley to capitalize on resurgent IPO markets. 'The backlog continues to build,' noted executives, with Q3 pipelines described as unusually robust—a sentiment echoed across Wall Street as capital markets awaken from their interest-rate-induced slumber.